Valeda Sham treatment

DEVICE2 trials

Sponsors

LumiThera, Inc.

Conditions

Dry Age-related Macular Degeneration

Unknown Phase

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)

CompletedNCT03878420

LumiThera, Inc.Dry Age-related Macular Degeneration

Start: 2019-02-14End: 2021-01-22Updated: 2021-09-02

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

Active, not recruitingNCT04065490

LumiThera, Inc.Dry Age-related Macular Degeneration

Start: 2019-09-01End: 2022-06-01Target: 96Updated: 2021-02-05

Related Papers

LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration

Ophthalmology and Therapy2023-01-0244 citations